Read more
March 2024
UK-wide radiologist network to deploy Caristo’s pioneering CaRi-Heart® solution Oxford, March 19, 2024— Heart & Lung Health (HLH), a UK-wide network of…
Read more
March 2024
Cardiovascular risk prediction models based on traditional risk factors underestimate risk in women – review article by European Atherosclerosis Society…
Read more
January 2024
Press Release Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment (LODOCO®– colchicine, 0.5 mg…
Read more
November 2023
Press Release Caristo’s AI Technology for Coronary Inflammation Measurement and Risk Assessment Can Transform Risk Stratification and Management of Patients…
Read more
October 2023
This clinical consensus statement from the European Society of Cardiology defines perivascular adipose tissue (PVAT) and highlights the biological mechanisms…
Read more
October 2023
Abstract: Patients with coronavirus disease 2019 (COVID-19) present increased risk for ischemic cardiovascular complications up to 1 year after infection. Although…
Read more
September 2023
Press Release British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day CaRi-Heart®…
Read more
September 2023
Jamie from Gloucestershire rides most days and lives a reasonably active life. She shares her experience of undergoing the CaRi-Heart®…
Get in touch for more information.